Literature DB >> 2946899

Interactions between macrophages and T-lymphocytes: tumor sneaking through intrinsic to helper T cell dynamics.

R J de Boer, P Hogeweg.   

Abstract

In a mathematical model of the cellular immune response we investigate immune reactions to tumors that are introduced in various doses. The model represents macrophage T-lymphocyte interactions that generate cytotoxic macrophages and cytotoxic T-lymphocytes. In this model antigens (tumors) can induce infinitely large T-lymphocyte effector populations because effector T-lymphocytes are capable of repeated proliferation and we have omitted immunosuppression. In this (proliferative) model small doses of weakly antigenic tumors grow infinitely large (i.e. sneak through) eliciting an immune response of limited magnitude. Intermediate doses of the same tumor induce larger immune responses and are hence rejected. Large doses of the tumor break through, but their progressive growth is accompanied by a strong immune response involving extensive lymphocyte proliferation. Similarly a more antigenic tumor is rejected in intermediate doses and breaks through in large doses. Initially small doses however lead to tumor dormancy. Thus although the model is devoid of explicit regulatory mechanisms that limit the magnitude of its response (immunosuppression is such a mechanism), the immune response to large increasing tumors may either be a stable reaction of limited magnitude (experimentally known as tolerance or unresponsiveness) or a strong and ever increasing reaction. Unresponsiveness can evolve because in this model net T-lymphocyte proliferation requires the presence of a minimum number of helper T cells (i.e. a proliferation threshold). Unresponsiveness is caused by depletion of helper T cell precursors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2946899     DOI: 10.1016/s0022-5193(86)80205-3

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  9 in total

1.  Unreasonable implications of reasonable idiotypic network assumptions.

Authors:  R J De Boer; P Hogeweg
Journal:  Bull Math Biol       Date:  1989       Impact factor: 1.758

2.  Stability of symmetric idiotypic networks--a critique of Hoffmann's analysis.

Authors:  R J De Boer; P Hogeweg
Journal:  Bull Math Biol       Date:  1989       Impact factor: 1.758

3.  Memory but no suppression in low-dimensional symmetric idiotypic networks.

Authors:  R J De Boer; P Hogeweg
Journal:  Bull Math Biol       Date:  1989       Impact factor: 1.758

4.  Modelling lymphoma therapy and outcome.

Authors:  Katja Roesch; Dirk Hasenclever; Markus Scholz
Journal:  Bull Math Biol       Date:  2013-12-14       Impact factor: 1.758

5.  Systemic distribution and tumor localization of adoptively transferred lymphocytes in mice: comparison with physiologically based pharmacokinetic model.

Authors:  Robert J Melder; Lance L Munn; Brian R Stoll; Edgardo M Marecos; Laurence T Baxter; Ralph Weissleder; Rakesh K Jain
Journal:  Neoplasia       Date:  2002 Jan-Feb       Impact factor: 5.715

6.  Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis.

Authors:  V A Kuznetsov; I A Makalkin; M A Taylor; A S Perelson
Journal:  Bull Math Biol       Date:  1994-03       Impact factor: 1.758

7.  Theoretical implications of cellular immune reactions against helper lymphocytes infected by an immune system retrovirus.

Authors:  G Reibnegger; D Fuchs; A Hausen; E R Werner; M P Dierich; H Wachter
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

8.  Mathematical Modeling, Analysis, and Simulation of Tumor Dynamics with Drug Interventions.

Authors:  Pranav Unni; Padmanabhan Seshaiyer
Journal:  Comput Math Methods Med       Date:  2019-10-08       Impact factor: 2.238

9.  Can the Kuznetsov Model Replicate and Predict Cancer Growth in Humans?

Authors:  Alexander Mitsos; Jakob Nikolas Kather; Mohammad El Wajeh; Falco Jung; Dominik Bongartz; Chrysoula Dimitra Kappatou; Narmin Ghaffari Laleh
Journal:  Bull Math Biol       Date:  2022-09-29       Impact factor: 3.871

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.